Ginkgo Bioworks Adopts INSCRIPTA’s Onyx Digital Genome Engineering Platform

The goal of Oncode-PACT is to create a state-of-the-art drug development infrastructure to innovate the cancer drug development process itself.

TARA's state-of-the-art in vitro human cardiac disease models combined with Valo's artificial intelligence-driven Opal platform – which is built on...

It is the first time in the industry that a self-contained implantable medical device is capable of generating its own energy when operated.